Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
3.590
-0.110 (-2.97%)
At close: Oct 15, 2026, 4:00 PM EDT
3.660
+0.070 (1.95%)
After-hours: Oct 15, 2026, 7:33 PM EDT
Unicycive Therapeutics Employees
As of December 31, 2025, Unicycive Therapeutics had 22 total employees, including 21 full-time and 1 part-time employees. The number of employees decreased by 1 or -4.35% compared to the previous year. That makes Unicycive Therapeutics the 38,137th largest employer in the world and 5,471st in the United States.
Employees
22
Change (1Y)
-1
Growth (1Y)
-4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,601,045
Market Cap
100.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | -1 | -4.35% | 21 | 1 |
| Dec 31, 2024 | 23 | 9 | 64.29% | 22 | 1 |
| Dec 31, 2023 | 14 | 2 | 16.67% | 14 | 0 |
| Dec 31, 2022 | 12 | 3 | 33.33% | 12 | 0 |
| Dec 31, 2021 | 9 | 8 | 800.00% | 9 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| LENZ Therapeutics | 152 |
| Tonix Pharmaceuticals Holding | 142 |
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| PMV Pharmaceuticals | 54 |
UNCY News
- 15 hours ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY - PRNewsWire
- 14 days ago - Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors to Seek a Leadership Role Before Deadline on November 2, 2026 - Newsfile Corp
- 14 days ago - Unicycive Therapeutics appoints Manning to its Board of Directors - TheFly
- 14 days ago - Unicycive Therapeutics Appoints Meredith Manning to Board of Directors - GlobeNewsWire
- 16 days ago - Kaplan Fox Notifies Investors of Unicycive Therapeutics, Inc. (UNCY) of the Lead Plaintiff Deadline on November 2, 2026 - Newsfile Corp
- 16 days ago - Unicycive Therapeutics price target lowered to $13 from $15 at H.C. Wainwright - TheFly
- 16 days ago - Unicycive Therapeutics announces resubmission of NDA for OLC - TheFly
- 16 days ago - Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate - GlobeNewsWire